Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for July 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Telemedicine Use Explodes During COVID-19 Pandemic
FRIDAY, July 31, 2020 (HealthDay News) — The emergence of telemedicine has accelerated during the coronavirus pandemic. HD Live! sat down with Rujuta Saksena, M.D., an oncologist at Overlook Medical Center in Summit, New Jersey, and Ateev Mehrotra, M.D., associate professor of health care policy at Harvard Medical School in Boston, to discuss the future of telemedicine and its impact on health care.
Inflammation Tied to Thyroid Dysfunction With Psoriasis
FRIDAY, July 31, 2020 (HealthDay News) — Thyroid dysfunction in patients with psoriasis may be associated with inflammation caused by psoriasis, according to a study published online June 22 in the Journal of Dermatology.
Abstract/Full Text (subscription or payment may be required)
Survivors of Adolescent, Young Adult ALL May Suffer Late Effects
FRIDAY, July 31, 2020 (HealthDay News) — Survivors of adolescent and young adult (AYA) acute lymphoblastic leukemia (ALL) may experience late effects, with a high incidence of subsequent endocrine disease and cardiac disease, according to a study published in the August issue of JNCI Cancer Spectrum.
Sex Differences in Income Vary With Proportion of Male Doctors
FRIDAY, July 31, 2020 (HealthDay News) — For surgical and nonsurgical specialists, sex differences in income vary with the proportion of male physicians in a practice, according to a study published online July 30 in The BMJ.
Cinnamon Supplementation May Improve Blood Glucose Control
THURSDAY, July 30, 2020 (HealthDay News) — In individuals with prediabetes, 12 weeks of cinnamon supplementation improved fasting plasma glucose (FPG) and glucose tolerance, according to a study published online July 21 in the Journal of the Endocrine Society.
Abstract/Full Text (subscription or payment may be required)
Chocolate Tied to Lower Coronary Artery Disease Risk
THURSDAY, July 30, 2020 (HealthDay News) — Eating chocolate at least once a week is associated with a lower risk for coronary artery disease (CAD), according to a review published online July 22 in the European Journal of Preventive Cardiology.
More Diabetic Foot Amputations Seen During COVID-19 Lockdown
WEDNESDAY, July 29, 2020 (HealthDay News) — Patients with diabetes admitted to a tertiary care center for diabetic foot ulceration (DFU) during the COVID-19 lockdown in Italy had a more than threefold risk for amputation versus patients seen in 2019, according to a study published online July 23 in Diabetes Care.
Abstract/Full Text (subscription or payment may be required)
Decrease Seen in Products Purchased Containing Caloric Sweeteners
Previous COVID-19 Tied to Increased Risk for Kidney Disease 
Predictors of Prediabetes/T2DM Identified Among U.S. Adolescents 
Differences in Cardiovascular Risk Factor Prevalence ID"d for South Asian Adults 
Sex Hormones Linked to Cardiovascular Events in Men With Type 2 Diabetes 
Weight Regain Seen After Cessation of GLP-1 Receptor Agonists in Adults With Overweight, Obesity 
Satisfaction With Semaglutide Driven by Effective Weight Loss 
Intermittent Fasting Seems to Have Little to No Effect for Adults With Overweight, Obesity 
Heart Disease, Stroke Account for More Than One in Four Deaths in U.S. 
